Novartis, Dr. Reddy's Deal Ends Exelon MDL

Law360, New York (January 22, 2008, 12:00 AM EST) -- Dr. Reddy's Laboraties Inc. and Novartis AG have ended the multidistrict litigation over dementia treatment Exelon, striking a settlement deal a month after defendants Sun Pharmaceuticals Industries Inc. and Watson Pharmaceuticals Inc. came to terms with Novartis.

Dr. Reddy's and Novartis filed a stipulation of dismissal in the U.S. District Court for the Southern District of New York on Jan. 18. The companies agreed that the claims and counterclaims at issue in the suit will be dismissed without prejudice.

Derek Sarafa of Winston & Strawn LLP,...
To view the full article, register now.